All In Biotech

Drug Trial Radar · NCT06169397

An Open-label Extension Study of XTMAB-16 in Patients With Pulmonary Sarcoidosis

A Long-term Multicenter Open-label Study to Evaluate the Long-term Safety and Durability of Effect of XTMAB-16 in Patients With Pulmonary Sarcoidosis With or Without Extra-pulmonary Involvement

Last checked: Nov 19, 2026Latest source record: Oct 16, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

31

Actual

Start

Mar 1, 2024

Primary completion

Oct 9, 2026

Study completion Oct 9, 2026

Sponsor

Lead sponsor
Xentria, Inc.Industry
Sponsor type
Industry
First posted
Dec 13, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Open-label Study to Evaluate the Long-term Safety and Durability of Effect of XTMAB-16 in Patients With Pulmonary Sarcoidosis With or Without Extra-pulmonary Involvement

Conditions

  • Pulmonary Sarcoidosis

Interventions

  • XTMAB-16Drug

    XTMAB-16 infusion

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Rate of Adverse Events (AEs), including Serious Adverse Events (SAEs), and Adverse Events of Special Interests (AESIs) throughout the study durationTime frame: Through study completion, an average of 4 years

Locations

11 sites in 4 countries. Site status is shown where the registry gives one.

  • Xentria Investigative Site

    Denver, Colorado

  • Xentria Investigative Site

    Chicago, Illinois

  • Xentria Investigative Site

    Greenville, North Carolina

  • Xentria Investigative Site

    Cincinnati, Ohio

  • Xentria Investigative Site

    Philadelphia, Pennsylvania

  • Xentria Investigative Site

    Prague, Czechia

  • Xentria Investigative Site

    Bielsk Podlaski, Poland

  • University Hospitals Coventry and Warwickshire NHS Trust

    Coventry, England, United Kingdom

  • King's College Hospital NHS Foundation Trust

    London, England, United Kingdom

  • Norfolk and Norwich University Hospitals NHS Foundation Trust

    Norwich, England, United Kingdom

  • NHS Tayside

    Perth, Scotland, United Kingdom

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.